Roivant Sciences Ltd.
ROIV
41 insider filings · Latest: Jun 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | Dec 26 1:02 PM | Sukhatme Mayukh | Proposed Sale | 185,946 | $12.00 | $2.2M | — | View → |
| Dec 23, 2024 | Dec 23 9:21 PM | Sukhatme Mayukh | Proposed Sale | 10,796 | $12.00 | $129.6K | — | View → |
| Nov 20, 2024 | Dec 20 9:29 PM | Venker Eric | Proposed Sale | 100,000 | $11.49 | $1.1M | — | View → |
| Dec 18, 2024 | Dec 18 9:33 PM | Sukhatme Mayukh | Proposed Sale | 412,584 | $12.05 | $5.0M | — | View → |
| Nov 20, 2024 | Nov 20 9:45 PM | Venker Eric | Proposed Sale | 100,000 | $11.32 | $1.1M | — | View → |
| Oct 21, 2024 | Oct 21 8:45 PM | Venker Eric | Proposed Sale | 100,000 | $11.65 | $1.2M | — | View → |
| Sep 25, 2024 | Sep 25 8:30 PM | BNEI ZAHAV LLC | Proposed Sale | 23,917 | $11.76 | $281.3K | — | View → |
| Sep 25, 2024 | Sep 25 8:25 PM | RIOJA DOLCE LLC | Proposed Sale | 170,817 | $11.76 | $2.0M | — | View → |
| Sep 25, 2024 | Sep 25 8:23 PM | KEITH S MANCHESTER REVOCABLE TRUST | Proposed Sale | 134,948 | $11.76 | $1.6M | — | View → |
| Sep 25, 2024 | Sep 25 8:20 PM | RIOJA LIETO LLC | Proposed Sale | 170,817 | $11.76 | $2.0M | — | View → |
| Sep 25, 2024 | Sep 25 8:19 PM | DANIEL GOLD & LAURA GOLD | Proposed Sale | 991,593 | $11.76 | $11.7M | — | View → |
| Sep 24, 2024 | Sep 24 11:53 PM | DANIEL GOLD &LAURA GOLD JT TEN | Proposed Sale | 1,565,670 | $11.62 | $18.2M | — | View → |
| Sep 24, 2024 | Sep 24 11:52 PM | RIOJA LIETO LLC | Proposed Sale | 269,712 | $11.63 | $3.1M | — | View → |
| Sep 24, 2024 | Sep 24 11:51 PM | RIOJA DOLCE LLC | Proposed Sale | 269,712 | $11.63 | $3.1M | — | View → |
| Sep 24, 2024 | Sep 24 11:48 PM | BNEI ZAHAV LLC | Proposed Sale | 37,762 | $11.62 | $439.0K | — | View → |
| Sep 24, 2024 | Sep 24 11:43 PM | KEITH S MANCHESTER REVOCABLE TRUST | Proposed Sale | 368,052 | $11.63 | $4.3M | — | View → |
| Sep 23, 2024 | Sep 23 8:53 PM | Gline Matthew | Proposed Sale | 1,983,257 | $11.79 | $23.4M | — | View → |
| Sep 23, 2024 | Sep 23 8:47 PM | Kumar Rakhi | Proposed Sale | 250,000 | $11.89 | $3.0M | — | View → |
← Previous
Page 6 of 6
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 2 11:03 PM | Meghan FitzgeraldDirector | Option Exercise | 10,000 | $8.80 | 38,578(D) | View → |
| Jun 29, 2026 | Jul 1 10:34 PM | Melissa B, EpperlyDirector | Option Exercise | 17,750 | $4.46 | 169,166(D) | View → |
| Jun 26, 2026 | Jun 29 10:23 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 500,000 | $3.85 | 14,224,363(D) | View → |
| Jun 25, 2026 | Jun 29 10:23 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 500,000 | $3.85 | 14,724,363(D) | View → |
| Jun 24, 2026 | Jun 26 10:13 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,244,834(D) | View → |
| May 22, 2026 | May 22 10:25 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,444,834(D) | View → |
| Apr 20, 2026 | Apr 22 10:27 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,644,834(D) | View → |
| Apr 20, 2026 | Apr 22 10:26 PM | Richard PulikCFO | Grant/Award | 84,026 | $29.08 | 84,026(D) | View → |
| Apr 20, 2026 | Apr 22 10:26 PM | Jennifer HumesChief Accounting Officer | Grant/Award | 27,157 | $29.08 | 27,157(D) | View → |
| Mar 30, 2026 | Apr 1 11:20 PM | Matthew GlineDirector, CEO | Option Exercise | 2,178,150 | — | 0(D) | View → |
| Mar 30, 2026 | Apr 1 11:19 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 1,306,889 | — | 0(D) | View → |
| Mar 26, 2026 | Mar 31 1:01 AM | Meghan FitzgeraldDirector | Option Exercise | 70,000 | $8.80 | 48,578(D) | View → |
| Mar 17, 2026 | Mar 19 10:36 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,844,834(D) | View → |
| Feb 23, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Option Exercise | 587,390 | $3.85 | 3,026,184(D) | View → |
| Feb 20, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Option Exercise | 1,012,610 | $3.85 | 3,613,574(D) | View → |
| Feb 19, 2026 | Feb 24 1:40 AM | Frank TortiPresident and Vant Chair | Option Exercise | 1,400,000 | $3.85 | 4,626,184(D) | View → |
| Feb 13, 2026 | Feb 18 10:57 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 5,044,834(D) | View → |
| Feb 9, 2026 | Feb 11 10:53 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 651,558 | $12.68 | 0(D) | View → |